Diagnostic options · UAE

Genetic tests in Dubai & UAE

Compare available Genetic tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

805

Listed price range

600.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetic test prices

Showing 181–195 of 805 matching tests.

Genetic diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-6065 CPT2 Gene Carnitine Palmitoyltransferase II Deficiency (Lethal Neonatal) Genetic Test This genetic test identifies pathogenic variants in the CPT2 gene associated with lethal neonatal carnitine palmitoyltransferase II deficiency.	Whole Blood (Venous), Extracted DNA, Dried Blood Spot on FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CPT2 gene sequence", "Copy Number Variations (CNVs) in CPT2 gene"] Parameters [] Preparation ["Inform phlebotomist of all current medications", "Do not discontinue prescribed medication without consulting physician"] Indications ["Suspected lethal neonatal CPT2 deficiency", "Neonatal metabolic crisis", "Family history of CPT2 deficiency"] Measurement technique Confirm with laboratory Codes LOINC: 101675-7 ICD-10: E71.312 Clinical summary This genetic test identifies pathogenic variants in the CPT2 gene associated with lethal neonatal carnitine palmitoyltransferase II deficiency.
TEST-3069 CRELD1 Gene Sequencing for Atrioventricular Septal Defect with Heterotaxy Syndrome Test This test detects pathogenic variants in the CRELD1 gene associated with autosomal dominant atrioventricular septal defect (AVSD) and heterotaxy syndrome.	Whole Blood, Extracted DNA, FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CRELD1 gene pathogenic variants", "Copy Number Variations (CNVs) in CRELD1"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed cardiac medications without consulting the treating cardiologist"] Indications ["Infants and children with congenital heart malformations", "Individuals with visceral situs anomalies", "At-risk family members"] Measurement technique Confirm with laboratory Codes LOINC: 94476-3 ICD-10: Q21.2, Q20.9 Clinical summary This test detects pathogenic variants in the CRELD1 gene associated with autosomal dominant atrioventricular septal defect (AVSD) and heterotaxy syndrome.
TEST-2954 CRLF1 Gene Cold-Induced Sweating Syndrome (CISS) Genetic Test This test uses next-generation sequencing to detect pathogenic variants in the CRLF1 gene, confirming a diagnosis of Cold-Induced Sweating Syndrome.	Whole blood (EDTA tube), extracted DNA, or FTA card (dried blood spot)	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CRLF1 gene sequence", "Pathogenic variants in CRLF1"] Parameters [] Preparation ["Detailed clinical history required", "Genetic counseling mandatory prior to sample collection", "No fasting or medication restriction needed unless specified by physician"] Indications ["Suspected Cold-Induced Sweating Syndrome", "Evaluation of patients with cold-induced sweating, dysmorphism, and contractures"] Measurement technique Confirm with laboratory Codes LOINC: 81247-7 ICD-10: Q87.8, Z13.79, Z15.09 Clinical summary This test uses next-generation sequencing to detect pathogenic variants in the CRLF1 gene, confirming a diagnosis of Cold-Induced Sweating Syndrome.
TEST-3529 CRYBB1 Gene Cataract Type 17 Genetic Testing Test This test identifies pathogenic variants within the CRYBB1 gene associated with congenital or early-onset cataract type 17.	Peripheral Whole Blood (3 mL in EDTA tube) or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in CRYBB1 gene coding exons and splice sites", "Single Nucleotide Variants (SNVs)", "Insertions/Deletions (indels)", "Copy number changes"] Parameters [] Preparation ["No fasting required", "Provide complete clinical history and pedigree chart", "Disclose all medications, especially blood thinners"] Indications ["Diagnosis of congenital or early-onset cataract type 17", "Family risk stratification for CRYBB1-related cataracts", "Genetic counseling for affected families"] Measurement technique Confirm with laboratory Codes LOINC: 82709-1 ICD-10: Q12.0, H26.9 Clinical summary This test identifies pathogenic variants within the CRYBB1 gene associated with congenital or early-onset cataract type 17.
TEST-3516 CRYBB3 Gene Cataract, Autosomal Recessive Congenital Nuclear Type 2 Genetic Test This test identifies pathogenic variants within the CRYBB3 gene associated with Autosomal Recessive Congenital Nuclear Cataract Type 2.	Whole Blood (Peripheral) or FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CRYBB3 gene", "Copy Number Variants (CNVs) in CRYBB3"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed ophthalmic drops or systemic medications without physician approval"] Indications ["Diagnosis of Autosomal Recessive Congenital Nuclear Cataract Type 2", "Family history of congenital cataracts", "Genetic counselling for family planning"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: Q12.0 Clinical summary This test identifies pathogenic variants within the CRYBB3 gene associated with Autosomal Recessive Congenital Nuclear Cataract Type 2.
TEST-4721 CSF1 Gene Osteogenesis and Dental Anomalies Genetic Test This test evaluates the CSF1 gene for pathogenic variants associated with autosomal recessive osteopetrosis, dental anomalies, and pigmentation disorders.	Peripheral whole blood (venous) or dried blood spot (FTA card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CSF1 gene coding region", "CSF1 gene exon-intron boundaries", "Copy Number Variants"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of all medications"] Indications ["Suspected autosomal recessive osteopetrosis", "Dental anomalies", "Pigmentation abnormalities"] Measurement technique Confirm with laboratory Codes LOINC: 21684-6 ICD-10: M85.8, K00.8, L81.9 Clinical summary This test evaluates the CSF1 gene for pathogenic variants associated with autosomal recessive osteopetrosis, dental anomalies, and pigmentation disorders.
TEST-5799 CSF2RA Gene Surfactant Metabolism Dysfunction Type 4 Genetic Test This genetic test identifies pathogenic variants in the CSF2RA gene associated with Surfactant Metabolism Dysfunction Type 4 (SMDP4).	Peripheral Whole Blood (EDTA) or Dried Blood Spot (FTA Card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CSF2RA gene sequence variants", "Copy Number Variants (CNV) in CSF2RA gene"] Parameters [] Preparation ["No special preparation or fasting is required."] Indications ["Suspected Surfactant Metabolism Dysfunction Type 4 (SMDP4)", "Neonatal interstitial lung disease of unknown etiology", "Family history of SMDP4"] Measurement technique Confirm with laboratory Codes LOINC: 81303-4 ICD-10: J84.89 Clinical summary This genetic test identifies pathogenic variants in the CSF2RA gene associated with Surfactant Metabolism Dysfunction Type 4 (SMDP4).
TEST-4027 CST3 Gene Cerebral Amyloid Angiopathy Genetic Test This test identifies pathogenic variants in the CST3 gene associated with hereditary cerebral amyloid angiopathy (CAA).	Peripheral whole blood (EDTA), extracted genomic DNA, or FTA card spot	21–28 calendar days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CST3 gene sequence variants", "Pathogenic mutations in the coding region and splice sites"] Parameters [] Preparation [] Indications ["Suspected hereditary cerebral amyloid angiopathy", "Family history of CAA", "Recurrent unexplained haemorrhagic strokes", "Progressive cognitive decline"] Measurement technique Confirm with laboratory Codes LOINC: 94218-7 ICD-10: I68.0 Clinical summary This test identifies pathogenic variants in the CST3 gene associated with hereditary cerebral amyloid angiopathy (CAA).
TEST-5846 CSTB Gene (Unverricht-Lundborg Disease) Genetic Test This test identifies mutations in the CSTB gene associated with Unverricht-Lundborg disease (EPM1), a form of progressive myoclonic epilepsy.	Peripheral whole blood (EDTA)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CSTB gene variants", "Single Nucleotide Variants (SNVs)", "Insertions/Deletions (indels)", "Copy Number Variations (CNV)"] Parameters [] Preparation ["No specific fasting required", "Avoid recent blood transfusions (within 12 weeks)"] Indications ["Suspected Unverricht-Lundborg disease", "Progressive myoclonic epilepsy", "Family history of EPM1"] Measurement technique Confirm with laboratory Codes LOINC: 21665-4 ICD-10: G40.3 Clinical summary This test identifies mutations in the CSTB gene associated with Unverricht-Lundborg disease (EPM1), a form of progressive myoclonic epilepsy.
TEST-6295 CTH Gene Cystathioninuria NGS Test This diagnostic test evaluates the CTH gene for pathogenic variants associated with cystathioninuria.	Whole Blood (EDTA), Extracted DNA, or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CTH gene sequence", "Pathogenic variants"] Parameters [] Preparation ["Genetic counselling session mandatory", "Provide family pedigree chart"] Indications ["Suspected cystathioninuria", "Familial screening for CTH gene variants", "Confirmation of diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 81247-7 ICD-10: E72.19, Z15.89, Z84.89 Clinical summary This diagnostic test evaluates the CTH gene for pathogenic variants associated with cystathioninuria.
TEST-3217 CTLA4 Gene Lymphoproliferative Syndrome, Autoimmune, Type 5 Genetic Test This test evaluates the CTLA4 gene for pathogenic variants associated with autoimmune lymphoproliferative syndrome type 5 (ALPS5). It provides a definitive molecular diagnosis for...	Peripheral Whole Blood	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CTLA4 gene", "Single Nucleotide Variants (SNVs)", "Insertions/Deletions (Indels)", "Copy Number Variants (CNVs)"] Parameters [] Preparation ["Provide detailed personal and family history of autoimmune or lymphoproliferative conditions.", "Pre-test genetic counselling is strongly recommended.", "No fasting is required for the blood draw."] Indications ["Suspected diagnosis of Autoimmune Lymphoproliferative Syndrome Type 5 (ALPS5)", "Evaluation of related immunodysregulation syndromes", "Family screening for CTLA4 pathogenic variants", "Guiding personalized treatment strategies"] Measurement technique Confirm with laboratory Codes LOINC: 82175-0 ICD-10: D89.82 Clinical summary This test evaluates the CTLA4 gene for pathogenic variants associated with autoimmune lymphoproliferative syndrome type 5 (ALPS5). It provides a definitive molecular diagnosis for this rare immunodeficiency disorder.
TEST-5445 CTNNA2 Gene Neuronal Migration Disorder Genetic Test This test identifies genetic variants in the CTNNA2 gene linked to neuronal migration disorders.	Blood, FTA Card, Extracted DNA	21–28 Calendar Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Single-nucleotide variants in CTNNA2 gene", "Small insertions/deletions in CTNNA2 gene", "Copy-number alterations in CTNNA2 gene"] Parameters [] Preparation [] Indications ["Suspected neuronal migration disorder", "Family history of neuronal migration disorder", "Diagnostic confirmation"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: Q04.8 Clinical summary This test identifies genetic variants in the CTNNA2 gene linked to neuronal migration disorders.
TEST-3612 CTRC Gene Pancreatitis Genetic Test This test evaluates the coding region of the CTRC gene for pathogenic variants associated with hereditary pancreatitis.	Peripheral whole blood, extracted DNA, or dried blood spot (FTA card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CTRC gene coding region", "Pathogenic variants in CTRC"] Parameters [] Preparation ["Clinical history documentation", "Three-generation family pedigree", "Mandatory genetic counselling session"] Indications ["Assessment of hereditary pancreatitis risk", "Family history of pancreatitis", "Clarification of inheritance patterns"] Measurement technique Confirm with laboratory Codes LOINC: 21656-6 ICD-10: K86.1 Clinical summary This test evaluates the coding region of the CTRC gene for pathogenic variants associated with hereditary pancreatitis.
TEST-3208 CUBN Gene Megaloblastic Anemia Type 1 (Finnish Type) Genetic Test This genetic test identifies pathogenic variants in the CUBN gene associated with Imerslund-Gräsbeck syndrome, a cause of vitamin B12 malabsorption.	Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CUBN gene", "Copy number variants (CNVs) in the CUBN gene"] Parameters [] Preparation ["No specific fasting required", "Avoid recent blood transfusions if possible"] Indications ["Suspected Imerslund-Gräsbeck syndrome", "Recurrent vitamin B12 deficiency unresponsive to supplementation", "Family history of megaloblastic anemia type 1", "Carrier screening"] Measurement technique Confirm with laboratory Codes LOINC: 94122-7 ICD-10: D51.1 Clinical summary This genetic test identifies pathogenic variants in the CUBN gene associated with Imerslund-Gräsbeck syndrome, a cause of vitamin B12 malabsorption.
TEST-3173 CYCS Gene Thrombocytopenia Type 4 Genetic Test This test evaluates the CYCS gene for pathogenic variants associated with congenital thrombocytopenia type 4.	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CYCS gene sequence", "Pathogenic variants", "Copy Number Variations (CNVs)"] Parameters [] Preparation ["No fasting required", "Mandatory pre-test genetic counseling session to document three-generation family pedigree"] Indications ["Suspected congenital thrombocytopenia type 4", "Family history of CYCS-related thrombocytopenia", "Need for definitive molecular diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 81499-9 ICD-10: D69.4 Clinical summary This test evaluates the CYCS gene for pathogenic variants associated with congenital thrombocytopenia type 4.

Category overview

Genetic: overview

Unlocking the blueprint of your DNA provides profound, proactive insights into your family’s future and personal health risks. Integrated within our advanced Biochemistry and molecular services, specialized Genetic testing evaluates inherited traits, metabolic predispositions, and carrier statuses. Utilizing cutting-edge diagnostic technology, comprehensive genetic screening offers the vital clarity needed to safely guide tailored medical strategies and family planning. As an undisputed leader in innovation among diagnostic labs in Dubai and the UAE, DNA Labs guarantees the highest standards of strict patient confidentiality, unparalleled diagnostic precision, and rapid reporting. Empower your health decisions with certainty—book your genetic testing in UAE, coordinate a secure sample collection, or connect with our specialized genetics team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.